Literature DB >> 1774303

Immunodiagnosis of toxocarosis in humans: evaluation of a new enzyme-linked immunosorbent assay kit.

P Jacquier1, B Gottstein, Y Stingelin, J Eckert.   

Abstract

Excretory/secretory (E/S) antigen derived from second-stage larvae of Toxocara canis maintained in defined medium in vitro has been well established worldwide for the immunodiagnosis of human toxocarosis by enzyme-linked immunosorbent assay. Such an enzyme-linked immunosorbent assay, based on the detection of human anti-T. canis (E/S antigen) serum immunoglobulin G, has recently been commercialized by Biokema-Affinity Products (Crissier-Lausanne, Switzerland). This commercial test kit was evaluated with regard to its application in a routine diagnostic laboratory and the reliability of the results. Of 78 patients with suspected clinical toxocarosis, 71 had anti-T. canis antibodies (positive serological result) corresponding to a diagnostic sensitivity of 91%; 14% of serum samples (n = 199) from patients with protozoan or with helminthic infections also showed positive reactions mainly related to infections with Trichinella, Strongyloides, and Fasciola species. An epidemiological study with 1,000 serum samples from randomly selected healthy blood donors and children in Switzerland demonstrated a seroprevalence of 2.7%. The test kit under evaluation had an overall diagnostic sensitivity of 91% and a relative specificity of 86%, the latter being related to some protozoan and helminthic infections. Because of the scarcity of such infections, potential cross-reactivity does not play a major role under the conditions found in the middle part of Europe. In conclusion, the application of the test kit provided for use in this study can be recommended for routine diagnostic use.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1774303      PMCID: PMC270219          DOI: 10.1128/jcm.29.9.1831-1835.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  In vitro maintenance of Toxocara canis larvae and a simple method for the production of Toxocara ES antigen for use in serodiagnostic tests for visceral larva migrans.

Authors:  D H Savigny
Journal:  J Parasitol       Date:  1975-08       Impact factor: 1.276

2.  Toxocariasis: serological diagnosis by enzyme immunoassay.

Authors:  D H de Savigny; A Voller; A W Woodruff
Journal:  J Clin Pathol       Date:  1979-03       Impact factor: 3.411

3.  The nature of visceral larva migrans.

Authors:  P C Beaver
Journal:  J Parasitol       Date:  1969-02       Impact factor: 1.276

4.  Purification and characterization of a specific antigen from Echinococcus multilocularis.

Authors:  B Gottstein
Journal:  Parasite Immunol       Date:  1985-05       Impact factor: 2.280

Review 5.  A critical look at the importance, prevalence and control of toxocariasis and the possibilities of immunological control.

Authors:  O O Barriga
Journal:  Vet Parasitol       Date:  1988-09       Impact factor: 2.738

6.  Seroepidemiological study on toxocaral infection in man by enzyme-linked immunosorbent assay.

Authors:  K Matsumura; R Endo
Journal:  J Hyg (Lond)       Date:  1983-02

7.  Specificity of Toxocara ELISA in tropical populations.

Authors:  N R Lynch; L K Wilkes; A N Hodgen; K J Turner
Journal:  Parasite Immunol       Date:  1988-05       Impact factor: 2.280

8.  The epidemiology of Toxocara canis.

Authors:  S H Gillespie
Journal:  Parasitol Today       Date:  1988-06

9.  Pica patterns, toxocariasis, and elevated blood lead in children.

Authors:  L T Glickman; I U Chaudry; J Costantino; F B Clack; R H Cypess; L Winslow
Journal:  Am J Trop Med Hyg       Date:  1981-01       Impact factor: 2.345

10.  Standardized nomenclature of animal parasitic diseases (SNOAPAD).

Authors:  T Kassai; M Cordero del Campillo; J Euzeby; S Gaafar; T Hiepe; C A Himonas
Journal:  Vet Parasitol       Date:  1988-10       Impact factor: 2.738

View more
  62 in total

1.  Molecular cloning of an immunogenic protein of Baylisascaris procyonis and expression in Escherichia coli for use in developing improved serodiagnostic assays.

Authors:  Sriveny Dangoudoubiyam; Ramesh Vemulapalli; Kathy Hancock; Kevin R Kazacos
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Toxocariasis masquerading as liver and lung metastatic nodules in patents with gastrointestinal cancer: clinicopathologic study of five cases.

Authors:  Sanghui Park; Yun Soo Kim; Yu Jin Kim; Sun Young Kyung; Jeong-Woong Park; Sung Hwan Jeong; Sang Pyo Lee
Journal:  Dig Dis Sci       Date:  2011-08-11       Impact factor: 3.199

3.  Recombinant antigen-based enzyme-linked immunosorbent assay for diagnosis of Baylisascaris procyonis larva migrans.

Authors:  Sriveny Dangoudoubiyam; Ramesh Vemulapalli; Momar Ndao; Kevin R Kazacos
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

4.  Natural infection of free-range chickens with the ascarid nematode Toxocara sp.

Authors:  Danielle R Campos-da-Silva; Jeanne S da Paz; Viviane R Fortunato; Marcus A V Beltrame; Luis C P Valli; Fausto E L Pereira
Journal:  Parasitol Res       Date:  2015-08-29       Impact factor: 2.289

5.  Pleural effusion and toxocariasis.

Authors:  T Jeanfaivre; B Cimon; N Tolstuchow; L de Gentile; D Chabasse; E Tuchais
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

6.  Coprological study on intestinal helminths in Swiss dogs: temporal aspects of anthelminthic treatment.

Authors:  H Sager; Ch Steiner Moret; F Grimm; P Deplazes; M G Doherr; B Gottstein
Journal:  Parasitol Res       Date:  2005-12-22       Impact factor: 2.289

7.  Development and evaluation of a sensitive and specific assay for diagnosis of human toxocariasis by use of three recombinant antigens (TES-26, TES-30USM, and TES-120).

Authors:  Suharni Mohamad; Norhaida Che Azmi; Rahmah Noordin
Journal:  J Clin Microbiol       Date:  2009-04-15       Impact factor: 5.948

8.  Seroprevalence of Toxocara infection in middle-class and disadvantaged children in northern Spain (Gipuzkoa, Basque Country).

Authors:  G Cilla; E Pérez-Trallero; C Gutiérrez; C Part; M Gomáriz
Journal:  Eur J Epidemiol       Date:  1996-10       Impact factor: 8.082

9.  Epidemiologic approach to human toxocariasis in western France.

Authors:  B Gueglio; L de Gentile; J M Nguyen; J Achard; D Chabasse; M Marjolet
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

10.  Recombinant expression of the larval excretory-secretory antigen TES-120 of Toxocara canis in the methylotrophic yeast Pichia pastoris.

Authors:  Mun-Yik Fong; Yee-Ling Lau
Journal:  Parasitol Res       Date:  2003-12-04       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.